Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 21, 2026
Touchlight has appointed Will Downie as interim chief executive officer, replacing Karen Fallen, who is stepping down after leading the company since November 2020.
read more
Wednesday, October 21, 2026
Zylidac Bio and Prolific Machines have partnered to move Prolific’s light-controlled protein production technology from laboratory development toward Good Manufacturing Practice production for clinical and commercial supply.
read more
Thursday, October 22, 2026
LGM Pharma has acquired Sannova Analytical, a contract research laboratory in Somerset, New Jersey, adding bioanalytical services and specialized impurity testing to its pharmaceutical testing business.
read more
Thursday, October 22, 2026
Medpace reported third-quarter revenue of $716 million, up 8.5% from a year earlier, while net income increased to $137.5 million from $111.1 million. Diluted earnings per share rose to $4.84 from $3.86.
read more
Made Scientific and CARR Biosystems have formed a partnership to install single-use centrifugation systems at two U.S. facilities, supporting manufacturing processes for mesenchymal stem cells and feeder cells used in allogeneic cell therapy programs...
read more
ESTEVE CDMO has invested more than $80 million to relocate, expand and modernize its manufacturing operations in China, adding a new facility in Shaoxing to its international contract development and manufacturing network.
read more
Aptar Pharma has acquired Pulmotree, a Munich-based company developing pulmonary drug delivery systems, adding a non-propellant inhaler platform to its respiratory device portfolio.
read more
BioAgilytix has opened a laboratory in Sydney through its Australian subsidiary, 360biolabs, expanding its capacity to process clinical trial samples and support early-phase drug development.
read more
Tuesday, October 27, 2026
Piramal Pharma Solutions’ Pithampur manufacturing site in India has won the company’s annual Excellence in Patient Centricity Award for a digital dashboard connecting production and supply data with estimates of patient reach.
read more
Thursday, October 29, 2026
Transpharmation has acquired Luxembourg-based OrganoTherapeutics, adding human stem cell-derived brain models to its preclinical contract research services for neurological drug development.
read more
Thursday, October 29, 2026
Codis has completed demolition and begun construction on an expansion at its Haverhill, United Kingdom, site that will add commercial-scale spray drying capacity for pharmaceutical manufacturing.
read more
Thursday, October 29, 2026
Adalvo has acquired global rights to Enzene’s romiplostim biosimilar program, while the Pune-based company will retain responsibility for development and manufacturing as it shifts toward a business focused entirely on biologics contract services.
read more
Monday, November 02, 2026
Coriolis Pharma has appointed Dr. Teun van der Heide as Chief Executive Officer, effective November 2, 2026. He succeeds Silvia Steyrer-Gruber, who led the company for the past four and a half years.
read more
Monday, November 02, 2026
Fresenius has entered an exclusive development agreement with WuXi Biologics that gives it exclusive access to up to 37 potential first-to-market biosimilar candidates over the next decade. The company called it the largest development agreement ...
read more
Monday, November 02, 2026
Kindeva has named Daniel Couto Executive Vice President, Inhalation & Specialty Drug Delivery. Couto joins the CDMO's executive leadership team with responsibility for the strategy, growth and performance of its global Inhalation & Specialty business...
read more